US29261A1007
US29261A1007
Encompass Health Corporation
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 12.17B EUR | 9.99B EUR | 9.62B EUR | 10.61B EUR |
Enterprise Value | 15.69B EUR | 12.72B EUR | 12.3B EUR | 13.26B EUR |
Valuation Multiples | ||||
Trailing P/E | 20.62x | 16.08x | 15.79x | 25.59x |
Forward P/E | 18.47x | -- | -- | -- |
Price to Sales | 1.96x | 1.61x | 1.59x | 2.37x |
Price to Book | 4.69x | 3.84x | 3.81x | 4.35x |
EV/Revenue | 2.53x | 2.05x | 2.03x | 2.96x |
EV/EBITDA | 10.72x | 8.46x | 8.41x | 12.57x |
Price to FCF (P/FCF) | 52.92x | 24.16x | 20.71x | 33.83x |
EV/FCF | 68.23x | 30.77x | 26.48x | 42.25x |
FCF Yield | 1.89% | 4.14% | 4.83% | 2.96% |